/ Where we treat

Last Updated: November 2, 2026

Ketamine Therapy in Delaware

Mindbloom provides evidence-based ketamine therapy to Delaware residents through a clinician-led telehealth program. Treatment is prescribed and supervised by a Delaware-licensed psychiatric clinician and delivered in the comfort of your home. Mindbloom offers two medication options: sublingual ketamine tablets and subcutaneous ketamine injections, making it the only at-home provider offering subcutaneous ketamine injections alongside the standard oral formulation.

Key takeaways

  • Statewide telehealth access: Mindbloom serves residents across all of Delaware via telehealth, including Wilmington, Dover, Newark, Middletown, Bear, Smyrna, Milford, Georgetown, Seaford, Lewes, Rehoboth Beach, and rural Delaware communities throughout New Castle, Kent, and Sussex Counties, with no in-person clinic visit required.
  • Published outcomes: In Mindbloom's 2022 peer-reviewed study of 1,247 clients using sublingual tablets, 89% reported improvement in depression or anxiety after four sessions 1; in its peer-reviewed study of subcutaneous injections (Parks et al. 2026, J Med Internet Res; n=623 with PTSD), 84.6% saw clinically meaningful improvement in PTSD symptoms by the end of the six-session course 3, and 76.8% of clients who completed treatment met criteria for sleep response. 4
  • Affordable pricing: Session costs for new clients range from $165-$215 depending on the program selected, approximately 60-70% less than in-clinic IV ketamine infusions available in neighboring states, and are HSA/FSA eligible.

How Mindbloom Works in Delaware

1. Complete an Online Assessment

Your journey begins with a comprehensive medical intake that gathers your health history, current medications, and treatment goals. A Delaware-licensed psychiatric clinician reviews your information to determine whether ketamine therapy is appropriate for your situation. This step is designed to screen for contraindications and ensure that treatment is both safe and clinically indicated.

2. Meet with a Delaware-Licensed Clinician

You'll have a video consultation with a psychiatric clinician licensed to practice in Delaware. During this appointment, your clinician screens for contraindications, discusses your mental health history, answers your questions, and, if appropriate, develops a personalized treatment plan. This includes selecting the right medication format (sublingual or subcutaneous) and establishing your dosing protocol.

3. Prepare for Your At-Home Sessions

Once your treatment plan is set, Mindbloom ships your Bloombox, an experience toolkit that includes everything you need for your sessions at home. You'll also arrange for a peer treatment monitor to be present during each session. This is a friend or family member you choose who stays nearby throughout the experience, offering support. You'll receive access to the Mindbloom app, which contains session preparation materials and guided content.

4. Conduct Sessions at Home

Right before your first session, you'll meet virtually with your guide to set intentions and prepare for the experience. Every Mindbloom client works with a dedicated guide, a trained psychedelic integration specialist who helps them prepare for each session and turn what comes up into lasting change. Guides are part of a care team led by licensed clinicians, who handle evaluation, prescribing, and dosing, and guides share safety and progress updates with them. During each session, you'll use the Mindbloom app to access one of over 150 curated soundscapes designed to support the therapeutic experience. Sessions typically last 60 to 90 minutes. Your peer treatment monitor remains present in your home throughout. Your Mindbloom guide walks them through the process and gives them the information and resources they need to feel comfortable in the role. They stay in a nearby room, checking in about every 15 minutes.

5. Integrate and Build on Your Progress

Between sessions, your Mindbloom guide provides 1:1 coaching and is available via unlimited messaging to help you process your experiences and translate insights into lasting change. You'll also have access to daily Integration Circles, live group sessions facilitated by trained practitioners, along with journaling prompts, breathing exercises, and other app-based tools designed to deepen the therapeutic benefit of each session.

Mindbloom's Published Outcomes for Depression, Anxiety, and PTSD

Mindbloom's clinical outcomes for depression and anxiety are drawn from two peer-reviewed studies of sublingual tablets published in the Journal of Affective Disorders 1,2, including the largest published study of at-home ketamine therapy, and a peer-reviewed study of subcutaneous injections published in the Journal of Medical Internet Research. 3 All data reflects outcomes from Mindbloom clients treated under Mindbloom's clinical protocol.

Depression

In Mindbloom's 2022 peer-reviewed study of 1,247 clients using sublingual tablets, 89% reported improvement in depression or anxiety after four sessions. 1 In the larger 2024 study of 11,441 clients, 56.4% met criteria for depression response and 28.1% reached remission. 2 In Mindbloom's peer-reviewed study of subcutaneous injections, by the end of the six-session course, 56.6% had a depression response and 27.7% reached remission (81.8% clinically meaningful improvement). 3

Anxiety

In Mindbloom's peer-reviewed study of 11,441 patients using sublingual tablets, 56.1% of the 7,776 with baseline anxiety scores responded. 2 In that group, 62.2% achieved clinically significant change in anxiety symptoms and 28.8% reached remission. 2 In the subcutaneous injection study, by the end of the six-session course, 60.6% had an anxiety response and 29.6% reached remission (80.0% clinically meaningful improvement). 3

PTSD

Mindbloom's peer-reviewed study of subcutaneous ketamine injections for PTSD found that, by the end of the six-session course, 84.6% saw clinically meaningful improvement, with a 76.7% response rate and 56.7% remission rate. 3 Mindbloom is the only at-home provider with peer-reviewed PTSD outcomes.

Sleep

In another retrospective real-world analysis of 13,963 clients, 76.8% of clients who completed treatment met criteria for sleep response. 4

Safety

In Mindbloom's published studies, side effects were reported by about 4 to 5% of participants per check-in with sublingual tablets 1,2 and 2.8 to 3.2% of participants per check-in with subcutaneous injections. 3 The most commonly reported effects, including nausea, dizziness, and transient dissociation, are typically mild and resolve within the post-session window.

Safety Protocols

Mindbloom's clinical program is built around multiple layers of medical oversight:

  • Medical screening: Before treatment begins, your clinician conducts a thorough evaluation for contraindications, including cardiovascular screening with blood pressure and heart rate assessment.
  • Session monitoring: A peer treatment monitor is required to be physically present during every session, providing real-time support and an additional layer of safety.
  • Follow-up care: Your clinician monitors your response to treatment and adjusts dosing or protocol as needed. Tolerability is assessed on an ongoing basis throughout your program.

Where Mindbloom Serves in Delaware

Mindbloom serves Delaware residents statewide through its telehealth platform, addressing a critical gap in mental health access across the state. Delaware, the second smallest state by area, faces significant disparities in mental health care distribution. Northern Delaware, anchored by the Wilmington metro area near Philadelphia, has relatively better access to providers, but central and southern Delaware face acute shortages. Sussex County in particular has limited psychiatric resources, leaving many residents with no local options for specialized treatment.

Mindbloom serves residents throughout Delaware, including: Wilmington, Dover, Newark, Middletown, Bear, Smyrna, Milford, Georgetown, Seaford, Lewes, Rehoboth Beach, and all surrounding communities across New Castle County, Kent County, and Sussex County.

Mindbloom is not limited to these areas. Any Delaware resident with a valid Delaware address can access the program.

How Ketamine Therapy Options Compare in Delaware

Several forms of ketamine therapy are available to Delaware residents, though many require travel to neighboring states, each with different settings, costs, and accessibility:

  • IV ketamine infusion: Administered intravenously at an in-clinic facility with on-site medical staff. Typically costs $400 to $800+ per infusion and is limited to major metro areas in Pennsylvania and neighboring states, requiring significant travel for most Delaware residents.
  • IM ketamine injection: Administered intramuscularly at an in-clinic facility with on-site medical staff. Typically costs $300-$600 per injection and is largely unavailable within Delaware.
  • Spravato (esketamine): An FDA-approved nasal spray administered in a certified healthcare setting with a required 2-hour post-dose observation period. Covered by some insurance plans; copays vary. Limited availability in Delaware.
  • Mindbloom: Sublingual tablet or subcutaneous injection administered at home with a peer treatment monitor present. Costs $165-$215 per session and is available to residents statewide via telehealth.

Ketamine is a Schedule III controlled substance that has been FDA-approved as an anesthetic since 1970. Its use for depression, anxiety, and PTSD is considered off-label, meaning the medication is being prescribed for a condition outside its original FDA indication. This is common across medicine: about 21% of U.S. office-based prescriptions are written for off-label uses (Radley et al., 2006). 8 Off-label prescribing is a well-established practice in medicine and is guided by a robust body of clinical research supporting how ketamine works for mental health conditions.

How Much Ketamine Therapy Costs in Delaware

In-clinic IV ketamine infusions typically cost $400 to $800+ per session when available in neighboring states, while IM injections range from $300 to $600. Spravato (esketamine) may be covered by some insurance plans, with copays varying. Mindbloom sessions cost $165-$215 depending on the program selected, representing savings of approximately 60-70% compared to in-clinic IV infusion options. Mindbloom sessions are HSA and FSA eligible, and Mindbloom provides superbills that you can submit to your insurance provider for potential out-of-network reimbursement. Learn more about insurance and payment options.

Why Delaware Residents Choose Mindbloom

  • Peer-reviewed research: Mindbloom's outcomes come from the actual program you'd enroll in, not a separate clinical trial, with depression and anxiety data published in the peer-reviewed Journal of Affective Disorders, PTSD data published in the peer-reviewed Journal of Medical Internet Research, and sleep data from additional clinical analyses.
  • Scale and experience: As of October 2026, Mindbloom has delivered more than 900,000 completed sessions and has the largest published evidence base in at-home ketamine therapy.
  • Subcutaneous option: Mindbloom is the only at-home provider offering subcutaneous ketamine injections, which gives clients an alternative to tablets if they prefer injections, want more flexibility, or tried tablets and didn't like them.
  • Comprehensive care model: Treatment extends well beyond the medication itself. Your program includes 1:1 guide coaching, unlimited messaging, daily Integration Circles, over 150 curated soundscapes, and app-based integration tools.
  • Statewide access: No in-person clinic visits required. Mindbloom's telehealth model reaches every corner of Delaware, from the Wilmington suburbs to rural communities in Kent and Sussex Counties.
  • Affordability: At $165-$215 per session with HSA/FSA eligibility and superbill support, Mindbloom makes ketamine therapy financially accessible.

How to Choose a Ketamine Therapy Provider in Delaware

When evaluating ketamine therapy providers, whether in-clinic or telehealth, consider the following:

  • Clinical oversight: Is treatment prescribed and monitored by a licensed psychiatric clinician? Is there a structured intake process with contraindication screening?
  • Published outcomes: Does the provider publish clinical outcomes from their own patient population? Is the data peer-reviewed?
  • Safety protocols: What monitoring is required during sessions? What happens if you experience a side effect or adverse reaction?
  • Integration support: Does the program offer support between sessions, such as coaching, integration tools, and group sessions, or is it medication-only?
  • Transparency: Is pricing clear? Are the clinician's credentials and the program's clinical protocol publicly available?

Mental Health in Delaware

Delaware ranked 19th overall in Mental Health America's 2025 report ⁵, placing it in the upper half of states, yet significant access gaps persist beneath that ranking. While the state's overall mental health provider ratio is essentially at the national average ⁶, roughly 40% of Delaware residents live in federally designated mental health professional shortage areas where less than 7% of the identified need is currently being met. ⁷ Available psychiatric services are concentrated in the Wilmington area near Philadelphia, while Kent and Sussex Counties remain substantially underserved. For Delaware residents living with depression, anxiety, PTSD, or related conditions like OCD, burnout, grief, and chronic pain, telehealth-based treatment offers a way to access specialized care without long wait times or travel to neighboring states.

Frequently asked questions

Is ketamine therapy available in Delaware?

Yes. Ketamine therapy is available in Delaware through telehealth-based at-home programs like Mindbloom. In-clinic options are extremely limited within the state, though some residents may access them in neighboring Pennsylvania and Maryland. Mindbloom serves all Delaware residents statewide.

Do I need to visit a clinic for ketamine therapy with Mindbloom?

Not with Mindbloom. Treatment is prescribed via telehealth and conducted at home. You'll meet with a Delaware-licensed clinician by video, and sessions take place in your own space with a peer treatment monitor present.

How quickly can ketamine therapy work?

Many clients report noticing changes within the first few sessions. However, individual responses vary, and your clinician will work with you to assess progress and adjust treatment as needed.

What conditions does Mindbloom treat?

Mindbloom's program is designed for adults experiencing depression, anxiety, and PTSD. Ketamine therapy may also be valuable for people dealing with related conditions like chronic pain, OCD, burnout, and grief, many of which overlap with anxiety and depression. Your clinician determines whether ketamine therapy is appropriate during the intake evaluation.

Is ketamine therapy safe?

Ketamine has been used in clinical settings since 1970 and has a well-established safety profile. Mindbloom's program includes medical screening, required peer treatment monitor presence during sessions, and ongoing clinician oversight. Mindbloom has delivered more than 900,000 sessions, and in its published studies, side effects were reported by about 4 to 5% of participants per check-in with sublingual tablets and 2.8 to 3.2% of participants per check-in with subcutaneous injections.

How much does ketamine therapy cost in Delaware?

Mindbloom sessions cost $165-$215 depending on the program selected. Treatment is HSA and FSA eligible. Most insurance plans do not cover off-label ketamine therapy directly, but Mindbloom provides superbills that you can submit for potential out-of-network reimbursement.

How does Mindbloom compare to traveling for ketamine therapy?

In-clinic options in neighboring states require travel, which can mean hours of driving from most parts of Delaware. Mindbloom delivers treatment to your home via telehealth, offers both sublingual and subcutaneous options, and includes integration support (guide coaching, Integration Circles, app tools) that many clinics do not provide, at approximately 60-70% lower cost.

Mindbloom Treatment

HSA/FSA ELIGIBLE
4.7/5

See what might be possible with clinician-guided, at-home ketamine therapy. New client programs start at $165 per session.

Get started

Keep us top of mind in your inbox.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

In this article

Text 1
0 References

Authors

Explore related articles

No items found.
No items found.